title: Does Concomitant Methotrexate During Rituximab Treatment in Granulomatosis With Polyangiitis (Wegener's) Increase the Risk of Severe Infection? Comment on the Article by Azar et al.
authors.affiliation: Institute of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway.
authors.forename: Emilio
authors.initials: E
authors.lastname: Besada
authors.affiliation: Haugesund Sanitetsforenings Revmatismesykehus, Haugesund, Norway.
authors.forename: Andreas P
authors.initials: AP
authors.lastname: Diamantopoulos
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D009173:Mycophenolic Acid; D001379:Azathioprine; D008727:Methotrexate